Mangoceuticals Statistics
Total Valuation
Mangoceuticals has a market cap or net worth of $22.51 million. The enterprise value is $22.48 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, after market close.
Earnings Date | May 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Mangoceuticals has 11.03 million shares outstanding. The number of shares has increased by 113.52% in one year.
Current Share Class | 11.03M |
Shares Outstanding | 11.03M |
Shares Change (YoY) | +113.52% |
Shares Change (QoQ) | +75.26% |
Owned by Insiders (%) | 9.80% |
Owned by Institutions (%) | 0.68% |
Float | 8.99M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 10.91 |
Forward PS | n/a |
PB Ratio | 0.72 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 43.99 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.12, with a Debt / Equity ratio of 0.00.
Current Ratio | 0.12 |
Quick Ratio | 0.05 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -689.73 |
Financial Efficiency
Return on equity (ROE) is -115.89% and return on invested capital (ROIC) is -60.45%.
Return on Equity (ROE) | -115.89% |
Return on Assets (ROA) | -53.55% |
Return on Invested Capital (ROIC) | -60.45% |
Return on Capital Employed (ROCE) | -46.66% |
Revenue Per Employee | $170,361 |
Profits Per Employee | -$4.02M |
Employee Count | 3 |
Asset Turnover | 0.05 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.87% in the last 52 weeks. The beta is 2.76, so Mangoceuticals's price volatility has been higher than the market average.
Beta (5Y) | 2.76 |
52-Week Price Change | -65.87% |
50-Day Moving Average | 1.89 |
200-Day Moving Average | 2.91 |
Relative Strength Index (RSI) | 52.44 |
Average Volume (20 Days) | 204,658 |
Short Selling Information
The latest short interest is 127,026, so 1.15% of the outstanding shares have been sold short.
Short Interest | 127,026 |
Short Previous Month | 277,446 |
Short % of Shares Out | 1.15% |
Short % of Float | 1.41% |
Short Ratio (days to cover) | 0.31 |
Income Statement
In the last 12 months, Mangoceuticals had revenue of $511,084 and -$12.05 million in losses. Loss per share was -$4.41.
Revenue | 511,084 |
Gross Profit | 294,630 |
Operating Income | -9.45M |
Pretax Income | -9.02M |
Net Income | -12.05M |
EBITDA | -8.31M |
EBIT | -9.45M |
Loss Per Share | -$4.41 |
Full Income Statement Balance Sheet
The company has $76,496 in cash and $47,713 in debt, giving a net cash position of $28,783 or $0.00 per share.
Cash & Cash Equivalents | 76,496 |
Total Debt | 47,713 |
Net Cash | 28,783 |
Net Cash Per Share | $0.00 |
Equity (Book Value) | 20.25M |
Book Value Per Share | 2.83 |
Working Capital | -1.33M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -6.15M |
Capital Expenditures | n/a |
Free Cash Flow | -6.15M |
FCF Per Share | -$0.56 |
Full Cash Flow Statement Margins
Gross Margin | 57.65% |
Operating Margin | -1,848.88% |
Pretax Margin | -2,187.33% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Mangoceuticals does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -113.52% |
Shareholder Yield | -113.52% |
Earnings Yield | -53.53% |
FCF Yield | -27.31% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on October 16, 2024. It was a reverse split with a ratio of 0.0666667:1.
Last Split Date | Oct 16, 2024 |
Split Type | Reverse |
Split Ratio | 0.0666667:1 |
Scores
Mangoceuticals has an Altman Z-Score of 0.67 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.67 |
Piotroski F-Score | 2 |